Jo Varshney is the founder and CEO of VeriSIM Life, an AI-driven bio-simulation platform that enables pharmaceutical companies to accelerate drug development. She has a PhD in Comparative Oncology and Genomics.
In this episode, we cover a range of topics including:
- State of play in AI-powered drug discovery
- Why is it so difficult to know which drug candidates to pursue?
- The founding of VeriSIM Life
- Role of AI in drug formulation
- Role of AI in drug repurposing
- Role of AI in drug-drug interaction
- How does AI help in evaluating potential toxic effects of a drug candidate?
- What should ML developers know about biochemistry? And about biochemists?
- Determing the efficacy
- De Novo drug design
- Patient stratification
- The future of AI powered drug discovery
Jo's favorite book: Built to Last (Author: Jim Collins)
--------
Where to find Prateek Joshi:
Newsletter: https://prateekjoshi.substack.com
Website: https://prateekj.com
LinkedIn: https://www.linkedin.com/in/prateek-joshi-91047b19
Twitter: https://twitter.com/prateekvjoshi
